-
Recent Posts
- 2025 Corvette ZR1 – 2.3 Seconds 0-60 MPH
- EU Car Sales Weak Again in November
- Supply Chain Resilience – U.S. DOT Four-Year Review
- CarMax FY Q3 Net Profit Up 1.2%
- Toyota to Get $4.5M in Fed Funding for EV Batteries
- California Advanced Clean Cars II Regs – EPA Grants Waivers!
- Clean Air Act – Power Performance Enterprises Fined
- Milestones – Sculptor Charles Sykes – Spirit of Ecstasy Creator
- US Auto Sales Forecast Trump Bump or Bumpy 25?
- Toyota Slashes 2025 Electric Vehicle Prices $6000
- Kenworth, Peterbuilt ABS Software Recall
- November Global Light Vehicle Sales Rate 93 Million
- Airports – More Safety, Capacity Improvements On Way
- Florida Man Pleads Guilty to Odometer Tampering
- December U.S. Auto Sales Start Strong
Recent Comments
- US Auto Sales Forecast Trump Bump or Bumpy 25? | AutoInformed on Trump Presidency Effects on Auto Industry – All Bad?
- Lisa Jacobson on Fossil Fuel Phase Out or Cop Out at COP28?
- Stellantis on Carlos Tavares Out as Stellantis CEO
- NHTSA Fines Ford $165M for Flouting Recall Law | AutoInformed on Ford Recalls Defective Rear-view Cameras on 620,246 Vehicles
- Alfa Romeo Returns to Formula 1 in 2018 via Sauber on Alfa Romeo Returns to Formula 1 in 2018 via Sauber
Archives
Meta
Get intelligent commentary on the automobile business and its economic and social effects. Stay informed with AutoInformed.
Commerce, HHS, FDA to Fight Online Opioid Sales
Under the program, the National Telecommunications and Information Administration (NTIA) and the U.S. Food and Drug Administration (FDA) will work with three domain name registries, Neustar (.us), Verisign (.com, .net) and Public Interest Registry (.org), to suspend the domain names of websites found to be illegally selling unapproved opioids. Continue reading →